Industry
Moximed
Total Trials
8
Recruiting
2
Active
2
Completed
4
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
Failure Rate
25.0%
2 terminated/withdrawn out of 8 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed trials have results
Key Signals
2 recruiting2 with results
Enrollment Performance
Analytics
N/A
7(100.0%)
7Total
N/A(7)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (8)
Showing 8 of 8 trials
NCT06843980Not ApplicableRecruiting
MOTION Clinical Trial
Role: lead
NCT06118892Not ApplicableRecruiting
MISHA Post-Market Clinical Study
Role: lead
NCT03671213Not ApplicableCompleted
Calypso Knee System Clinical Study
Role: lead
NCT03838978Not ApplicableCompleted
Calypso Knee System Clinical Study, OUS
Role: lead
NCT02934659Not ApplicableCompleted
Atlas Knee System Clinical System Clinical Study (USA)
Role: lead
NCT04548882Not ApplicableWithdrawn
Calypso Knee System Clinical Sub-study, OUS Continued Evaluation
Role: lead
NCT02663414Not ApplicableWithdrawn
European Post-Market Study for Medial Knee Osteoarthritis Treated With the Atlas Knee System for Load Reduction
Role: lead
NCT02934672Completed
KineSpring® System Patient Preference Study
Role: lead
All 8 trials loaded